跳至主要内容
临床试验/NCT02539628
NCT02539628已完成4 期

Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption: A Randomized, Triple-masked, Controlled Study

Pia Jaeger1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
Total opioid consumption

研究概览

简要总结

The investigators believe sufficient spread to all nerves within the adductor canal-and thereby sufficient analgesia-can only be obtained by bolus injections and not by continuous infusions via a catheter. The aim of the study is to investigate whether an adductor canal block performed as repeated intermittent boluses provides superior pain relief to continuous infusion. The investigators hypothesize that adductor canal block performed as intermittent boluses via a catheter will reduce morphine consumption and pain as well as enhance ambulation and muscle strength compared with continuous infusion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for total knee arthroplasty in spinal anesthesia
  • Patients who gave their written informed consent to participating in the study after having fully understood the contents of the protocol and restrictions
  • American society of anesthesiologists 1-3
  • Ability to perform a timed up and go test preoperatively

排除标准

  • Patients who cannot cooperate
  • Patients who cannot understand or speak Danish.
  • Patients with allergy to the medicines used in the study
  • Patients with a daily intake of strong opioids (morphine, oxycodone, ketobemidone, methadone, fentanyl) during the last 4 weeks
  • Patients suffering from alcohol and/or drug abuse - based on the investigator's assessment
  • Rheumatoid arthritis
  • BMI > 40
  • Neuromuscular pathology in the lower limbs
  • Pregnancy

研究组 & 干预措施

Intermittent bolus

Experimental

ropivacaine 0.2%, 21 ml every 3 hours

干预措施: ropivacaine 0.2% (Drug)

Continuous infusion

Active Comparator

ropivacaine 0.2%, 7ml/h

干预措施: ropivacaine 0.2% (Drug)

结局指标

主要结局

Total opioid consumption

时间窗: 2 days postoperative

Difference in total opioid consumption (patient controlled analgesia pump and any potential rescue administration) between groups, from end of surgery until 12 pm on postoperative day (POD) 2.

次要结局

  • Pains scores during knee flexion as assessed by the Visual analogue scale (VAS)(2 days postoepratively)
  • 6 min walk test(1 and 2 days postoperativley)
  • Quadriceps strength assessed as maximum voluntary isometric contraction in percentage of preoperative baseline values at 12 pm on POD 1 and 2(1 and 2 days postoperatively)
  • Timed Up and Go test(1 and 2 days postoperatively)
  • Number of patients able to perform the Timed Up and Go test(1 and 2 days postoperatively)
  • Pain at rest as assessed by the VAS pain scores(2 days postoperatively)
  • Pain during the Timed Up and Go test as assessed by the VAS(1 and 2 days postoperatively)

研究者

发起方
Pia Jaeger
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Pia Jaeger

Sponsor-Investigator

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验